SUMO1 and hepatocellular carcinoma: Indeed, considering that SUMO1 is directly involved in HCC by promoting p65 nuclear translocation and regulating NFκB activity [90], the alteration of the sumoylation/desumoylation machinery by HNK could well be responsible for the observed anticancer effect of the compound in HCC.